BioSpace News Archive

Amgen announced that it will host a webcasted call for the investment community at 8:00 a.m. ET on Tuesday, Oct. 24, 2023.

Apollo Medical Holdings, Inc. announced that it will release financial results for the third quarter ended September 30, 2023, after the close of the stock market on Tuesday, November 7, 2023.

Hyperfine, Inc. announced that it will report financial results for the third quarter 2023 on Thursday, November 9, 2023.

Invitae, a leading medical genetics company, announced the appointment of veteran healthcare leader David Sholehvar, M.D., as chief operating officer, effective November 13, 2023.

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the second quarter ended September 30, 2023, after the close of market on Thursday, October 26, 2023.

CEL-SCI Corporation reported that its Multikine* cGMP state-of-the-art dedicated manufacturing facility commissioning is substantially complete, a significant milestone toward a planned Biologics License Application with several regulatory agencies for approval of Multikine in the treatment of head and neck cancer.

Avinger, Inc. today announced that it will release its financial results for the third quarter 2023 after the close of trading on Thursday, October 26, 2023.

Immunome , Inc. today announced the appointment of Bob Lechleider, M.D., as Chief Medical Officer.

Summit Therapeutics Inc. announced that Howard “Jack” West, MD, has joined Summit Therapeutics as Vice President of Clinical Development focused on lung cancer.

Vaxcyte, Inc. (Nasdaq: PCVX) announced today that the U.S. Food and Drug Administration (FDA) has cleared the Company’s adult Investigational New Drug (IND) application for VAX-31, a 31-valent pneumococcal conjugate vaccine (PCV) candidate designed to prevent invasive pneumococcal disease (IPD).